Author

Anna Permyakova

Hebrew University of JerusalemORCID 0000-0003-3016-050XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1 Neuroscience· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 3 Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Approach:statistical model· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Joseph TamiD· 3 shared Bella Agranovich· 2 shared Eyal GottliebiD· 2 shared Ifat AbramovichiD· 2 shared Alexander LossosiD· 1 shared Alina NemirovskiiD· 1 shared Amani ZoabiiD· 1 shared Amijai SaragoviiD· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersPharmacology & Toxicology

Joseph TamORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintAug 5, 2026

Peripheral CB1R Blockade Suppresses AKI-to-CKD Maladaptive Repair

Ariel Rothner, Liad Hinden, Aviram Kogot‐Levin…·Joseph Tam

This study shows that blocking CB1R during kidney repair after AKI prevents CKD by reducing inflammation and metabolic dysregulation.

DOI 10.64898/2026.07.31.741993

𝕏 PostBluesky

ImmunologyNature CommunicationsPeer-reviewedMay 8, 2025

Metabolic Reprogramming Driven by Ant2 -Targeting Augments T-Cell Function and Anti-Tumor Immunity

Omri Yosef, Leonor Cohen‐Daniel, Oded Shamriz…·Michael Berger

This study shows that Ant2 deficiency enhances T-cell function and anti-tumor immunity by altering mitochondrial metabolism and metabolic reprogramming.

7 citations

mousebulk RNA-seq

𝕏 PostBluesky

NeurosciencebioRxivPreprintMar 18, 2021

A new drug candidate for glycogen storage disorders enhances glycogen catabolism: Lessons from Adult Polyglucosan Body Disease models

Hilla Vaknin, Kumudesh Mishra, Jeevitha D’Souza…·Miguel Weil

This study demonstrates that 144DG11 improves survival and motor function in APBD mouse models by promoting autophagic glycogen catabolism through LAMP1 interaction.

DOI 10.1101/2021.03.18.436069

mouseproteomics

𝕏 PostBluesky